New plant to supply vaccines to Central and Latin America region

Russia and Nicaragua have completed the establishment of a joint venture for the production of vaccines, according to press-service of the Russian federal government.

The new plant, which is located in Managua, Nicaragua's capital, will specialize in the production of influenza vaccines for countries of Central and Latin America and will be one of the largest of its kind in the entire region.

According to Veronika Skvortsova, Russia’s Minister of Health, the current deficit of vaccines in the Central American and Latin American regions is estimated at 150 million doses, however the establishment of the new plant will help to partially solve this problem.